These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30573981)

  • 1. Erratum: A small compound spindlactone A sensitizes human endometrial cancer cells to TRAIL-induced apoptosis via the inhibition of NAD(P)H dehydrogenase quinone 1 [Corrigendum].
    Onco Targets Ther; 2018; 11():8943. PubMed ID: 30573981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small compound spindlactone A sensitizes human endometrial cancer cells to TRAIL-induced apoptosis via the inhibition of NAD(P)H dehydrogenase quinone 1.
    Zhao XZ; Wu XH
    Onco Targets Ther; 2018; 11():3609-3617. PubMed ID: 29950865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum.
    Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum].
    Onco Targets Ther; 2017; 10():2779-2780. PubMed ID: 28615957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells [Erratum].
    Onco Targets Ther; 2018; 11():2203. PubMed ID: 29714361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of
    Onco Targets Ther; 2018; 11():2277. PubMed ID: 29749971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.
    Llobet D; Eritja N; Encinas M; Llecha N; Yeramian A; Pallares J; Sorolla A; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X
    Oncogene; 2008 Apr; 27(18):2513-24. PubMed ID: 17982483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum.
    Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
    J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells [Corrigendum].
    Onco Targets Ther; 2018; 11():687. PubMed ID: 29443312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer [Corrigendum].
    Int J Nanomedicine; 2017; 12():8375-8376. PubMed ID: 29200849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: ATR inhibition sensitizes liposarcoma to doxorubicin by increasing DNA damage.
    Cui J; Dean D; Hornicek FJ; Pollock RE; Hoffman RM; Duan Z
    Am J Cancer Res; 2023; 13(10):5021-5023. PubMed ID: 37970365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Corrigendum].
    Onco Targets Ther; 2015; 8():365. PubMed ID: 25676591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba.
    Ott CL; Ratna N; Prayag R; Badiani K; Navaratnam S
    Curr Oncol; 2012 Feb; 19(1):e42. PubMed ID: 22328847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum to "Microfluidic System Based High Throughput Drug Screening System for Curcumin/TRAIL Combinational Chemotherapy in Human Prostate Cancer PC3 Cells" [Biomol. Ther. 22 (2014) 355-362].
    An D; Kim K; Kim J
    Biomol Ther (Seoul); 2014 Sep; 22(5):475. PubMed ID: 25412825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum].
    Breast Cancer (Dove Med Press); 2018; 10():51. PubMed ID: 29589598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum].
    Int J Womens Health; 2015; 7():403. PubMed ID: 25960676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1.
    Jang JH; Lee TJ; Yang ES; Min do S; Kim YH; Kim SH; Choi YH; Park JW; Choi KS; Kwon TK
    Exp Cell Res; 2010 Aug; 316(13):2194-203. PubMed ID: 20451517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [Corrigendum].
    Onco Targets Ther; 2017; 10():2737-2738. PubMed ID: 28603422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Ethical and legal considerations regarding the ownership and commercial use of human biological materials and their derivatives [Corrigendum].
    J Blood Med; 2018; 9():193. PubMed ID: 30464669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Biophysical and biological contributions of polyamine-coated carbon nanotubes and bidimensional buckypapers in the delivery of miRNAs to human cells [Corrigendum].
    Int J Nanomedicine; 2018; 13():3729. PubMed ID: 29983565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.